Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Minerva Endocrinologica|January 10, 2002
[Current role of radiotherapy in the treatment of SCLC]L Busutti
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinomaL Busutti, A Breccia, G Stagni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)A Martoni, M Guaraldi, M Casadio, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivoL Busutti, A Breccia, E Ferri, et al.
La Clinica Terapeutica|July 9, 1999
[Transcutaneous radiotherapy after thyroidectomy for differentiated thyroid carcinoma]L Busutti, A B Blotta, G Calò-Gabrieli, et al.
Lymphokine Research|January 1, 1988
Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot studyG Pizza, D Viza, C De Vinci, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2011
Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancerL Fuccio, A Guido, L Laterza, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapyV Pilotti, M Mastrorilli, G Pizza, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1990
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposideM Casadio, G Lelli, S Giordani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2001
Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormoneA David, A Blotta, M Bondanelli, et al.
Pageof 2